Effectiveness and tolerability of long-acting intramuscular risperidone as adjuvant treatment in refractory borderline personality disorder

Saved in:
Bibliographic Details
Published inPsychopharmacology Vol. 224; no. 2; pp. 347 - 348
Main Authors Carrasco, J. L., Palomares, N., Marsá, M. Díaz
Format Journal Article
LanguageEnglish
Published Berlin/Heidelberg Springer-Verlag 01.11.2012
Springer
Springer Nature B.V
Subjects
Adolescent
Adult
Antipsychotic Agents - administration & dosage
Antipsychotic Agents - adverse effects
Antipsychotic Agents - therapeutic use
Antipsychotic drugs
Anxiety
Biomedical and Life Sciences
Biomedicine
Borderline Personality Disorder
Care and treatment
Compliance
Delayed-Action Preparations
Drug Therapy, Combination
Female
Humans
Injections, Intramuscular
Letter to the Editor
Male
Middle Aged
Neurosciences
Oral administration
Pharmacology/Toxicology
Psychiatry
Psychopharmacology
Risperidone - administration & dosage
Risperidone - adverse effects
Risperidone - therapeutic use
Suicides & suicide attempts
Young Adult
France
Spain
Madrid Spain
Borderline Personality Disorder
Risperidone
Clinical Global Impression
Borderline Personality Disorder Patient
Online AccessGet full text

Cover

More Information
ISSN:0033-3158
1432-2072
DOI:10.1007/s00213-012-2880-0